Showing results (311-320 of 757) with videos related to
Sort By:
Pageof 76
Renal Failure|July 28, 2021
Acute kidney injury after in-hospital cardiac arrest in a predominant internal medicine and cardiology patient population: incidence, risk factors, and impact on survivalSammy Patyna, Kirsten Riekert, Stefan Buettner, et al.Life Science Alliance|February 3, 2022
Proteomic landscape of SARS-CoV-2- and MERS-CoV-infected primary human renal epithelial cellsAneesha Kohli, Lucie Sauerhering, Sarah K Fehling, et al.Biochemical Pharmacology|December 31, 2002
Effects of high glucose on cytokine-induced nerve growth factor (NGF) expression in rat renal mesangial cellsKlaus Heese, Karl-Friedrich Beck, Meik Helmut Behrens, et al.Prostaglandins & Other Lipid Mediators|July 14, 2019
Blood ceramides as novel markers for renal impairment in systemic lupus erythematosusSammy Patyna, Stefan Büttner, Timon Eckes, et al.European Heart Journal. Cardiovascular Pharmacotherapy|January 31, 2020
Glucagon-like peptide-1 receptor agonists and the risk of cardiovascular events in diabetes patients surviving an acute myocardial infarctionMarco Trevisan, Edouard L Fu, Karolina Szummer, et al.Journal of Nephrology|May 14, 2022
Clinical characteristics and disease outcomes in non-diabetic chronic kidney disease: retrospective analysis of a US healthcare claims databaseChristoph Wanner, Johannes Schuchhardt, Chris Bauer, et al.Nature Reviews. Disease Primers|November 24, 2017
Chronic kidney diseasePaola Romagnani, Giuseppe Remuzzi, Richard Glassock, et al.Nephron. Physiology|July 2, 2005
L-Arginine does not affect renal morphology and cell survival in ischemic acute renal failure in ratsUlrike Raff, Reinhard Schneider, Stepan Gambaryan, et al.Kidney International|August 20, 2010
National Kidney Foundation consensus conference on cardiovascular and kidney diseases and diabetes risk: an integrated therapeutic approach to reduce eventsGeorge Bakris, Joseph Vassalotti, Eberhard Ritz, et al.BMC Neurology|May 28, 2013
Impaired small fiber conduction in patients with Fabry disease: a neurophysiological case-control studyNurcan Üçeyler, Ann-Kathrin Kahn, Daniela Kramer, et al.Pageof 76